Investing

First Look Analysts Research Calls for Tuesday, March 21

Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today. 

Upgrades:

> Assurant (AIZ) upgraded to Outperform from Mkt Perform at Keefe Bruyette; tgt $52

> Emerson (EMR) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $96

> FleetCor (FLT) upgraded to Outperform from Mkt Perform at Raymond James; tgt $254

> Foot Locker (FL) upgraded to Buy from Neutral at Citigroup; tgt raised to $50

> Foot Locker (FL) upgraded to Outperform from In-line at Evercore ISI; tgt $60

> Harley-Davidson (HOG) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt $50

> Imperial Oil (IMO) upgraded to Sector Outperform from Sector Perform at Scotiabank

> Meta Platforms (META) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt raised to $250

> New York Community (NYCB) upgraded to Buy from Neutral at DA Davidson; tgt $11.50

> ORIC Pharmaceuticals (ORIC) upgraded to Buy from Neutral at Guggenheim; tgt $15

> TotalEnergies SE (TTE) upgraded to Overweight from Equal-Weight at Morgan Stanley

> Vornado Rlty Trust (VNO) upgraded to Neutral from Underweight at Piper Sandler; tgt lowered to $16

> Wix.com (WIX) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $120

Downgrades:

> Agree Realty (ADC) downgraded to Mkt Perform from Mkt Outperform at JMP Securities

> Armstrong World Industries (AWI) downgraded to Hold from Buy at Deutsche Bank; tgt lowered to $77

> GoDaddy (GDDY) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $88

> Profound Medical (PROF) downgraded to Hold from Buy at Jefferies; tgt raised to $10

> Suncor Energy (SU) downgraded to Sector Perform from Sector Outperform at Scotiabank

> Sutro Biopharma (STRO) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $8

Others:

> Allogene (ALLO) initiated with a Mkt Perform at Bernstein; tgt $6

> Alnylam Pharma (ALNY) initiated with an Outperform at Bernstein; tgt $243

> Alphabet A (GOOGL) resumed with a Buy at Stifel; tgt $130

> Arrowhead (ARWR) initiated with a Mkt Perform at Bernstein; tgt $27

> Beam Therapeutics (BEAM) initiated with a Mkt Perform at Bernstein; tgt $37

> BioMarin Pharmaceutical (BMRN) initiated with an Underperform at Bernstein; tgt $81

> Boston Properties (BXP) resumed with a Neutral at Goldman; tgt $56

> Brixmor Property (BRX) resumed with a Neutral at Goldman; tgt $22

> Chart Industries (GTLS) initiated with an Outperform at Evercore ISI; tgt $217

> CONMED (CNMD) initiated with an Equal Weight at Wells Fargo; tgt $96

> CRISPR Therapeutics (CRSP) initiated with a Mkt Perform at Bernstein; tgt $44

> First Industrial Realty (FR) resumed with a Sell at Goldman; tgt $48

> Hudson Pacific Properties (HPP) resumed with a Sell at Goldman; tgt $5.50

> Intellia Therapeutics (NTLA) initiated with an Outperform at Bernstein; tgt $54

> Ionis Pharma (IONS) initiated with an Underperform at Bernstein; tgt $31

> Kilroy Realty (KRC) resumed with a Buy at Goldman; tgt $41

> Kimco Realty (KIM) resumed with a Buy at Goldman; tgt $25

> Macerich (MAC) resumed with a Sell at Goldman; tgt $8.50

> Phillips Edison & Company (PECO) resumed with a Buy at Goldman; tgt $38

> Prologis (PLD) resumed with a Buy at Goldman; tgt $147

> Simon Properties (SPG) resumed with a Buy at Goldman; tgt $150

> SL Green Realty (SLG) resumed with a Sell at Goldman; tgt $18

> Tanger Factory (SKT) resumed with a Buy at Goldman; tgt $22

> Ventyx Biosciences (VTYX) initiated with an Overweight at Wells Fargo; tgt $77

> Vertex Pharma (VRTX) initiated with an Outperform at Bernstein; tgt $344

> Vornado Rlty Trust (VNO) resumed with a Sell at Goldman; tgt $12

> Zymeworks (ZYME) assumed with an Overweight at Wells Fargo; tgt $12

The #1 Thing to Do Before You Claim Social Security (Sponsor)

Choosing the right (or wrong) time to claim Social Security can dramatically change your retirement. So, before making one of the biggest decisions of your financial life, it’s a smart idea to get an extra set of eyes on your complete financial situation.

A financial advisor can help you decide the right Social Security option for you and your family. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you.

Click here to match with up to 3 financial pros who would be excited to help you optimize your Social Security outcomes.

 

Have questions about retirement or personal finance? Email us at [email protected]!

By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.

By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.